BACKGROUND: Fetuin A, a predictor of cardio-vascular (CV) mortality in dialysis patients has been associated with dyslipidemia in non-diabetic coronary artery disease. Truncal obesity is linked to dyslipidemia and also predicts CV mortality. This study had aimed to investigate the associations among fetuin A, truncal obesity, and dyslipidemia in hemodialysis (HD) patients. METHODS: One hundred and nine non-diabetic HD patients were evaluated. Waist circumference, highly sensitive C-reactive protein (hs-CRP), fetuin A, and lipoprotein levels (i.e. total cholesterol (T-CHO), low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), non-HDL-C, and triglyceride (TG)) were measured for analysis of correlations. The patients were divide...
BACKGROUND/AIMS: Clinical studies have shown increased levels of hepcidin causing functional iron de...
<b><i>Background:</i></b> Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patient...
Calcifying atherosclerosis is an active process, which is controlled by calcification inhibitors and...
Fetuin A, a predictor of cardio-vascular (CV) mortality in dialysis patients has been associated wit...
Background: Fetuin A, a predictor of cardio-vascular (CV) mortality in dialysis patients, has been a...
Background: A deficiency of fetuin A is linked to cardiovascular calcification and mortality in dial...
Background: A deficiency of fetuin A is linked to cardiovascular calcification and mortality in dial...
Background: Cardiovascular disease (CVD) is the leading cause of mortality in hemodialysis (HD). An ...
Introduction: Cardiovascular disease is one of the main causes of death in patients with chronic kid...
Background. Fetuin-A (α 2-Heremans Schmid glycoprotein) has recently been identified as a circulatin...
ObjectiveIncreased body mass index (BMI) is associated with reduced all-cause and cardiovascular (CV...
BACKGROUND: Fetuin A, a circulating inhibitor of ectopic calcification, is downregulated in hemodial...
BACKGROUND: Fetuin A, a circulating inhibitor of ectopic calcification, is downregulated in hemodia...
BACKGROUND:Fetuin A, a circulating inhibitor of ectopic calcification, is downregulated in hemodialy...
Background: Iron supplementation is a common recommendation to chronic kidney disease patients under...
BACKGROUND/AIMS: Clinical studies have shown increased levels of hepcidin causing functional iron de...
<b><i>Background:</i></b> Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patient...
Calcifying atherosclerosis is an active process, which is controlled by calcification inhibitors and...
Fetuin A, a predictor of cardio-vascular (CV) mortality in dialysis patients has been associated wit...
Background: Fetuin A, a predictor of cardio-vascular (CV) mortality in dialysis patients, has been a...
Background: A deficiency of fetuin A is linked to cardiovascular calcification and mortality in dial...
Background: A deficiency of fetuin A is linked to cardiovascular calcification and mortality in dial...
Background: Cardiovascular disease (CVD) is the leading cause of mortality in hemodialysis (HD). An ...
Introduction: Cardiovascular disease is one of the main causes of death in patients with chronic kid...
Background. Fetuin-A (α 2-Heremans Schmid glycoprotein) has recently been identified as a circulatin...
ObjectiveIncreased body mass index (BMI) is associated with reduced all-cause and cardiovascular (CV...
BACKGROUND: Fetuin A, a circulating inhibitor of ectopic calcification, is downregulated in hemodial...
BACKGROUND: Fetuin A, a circulating inhibitor of ectopic calcification, is downregulated in hemodia...
BACKGROUND:Fetuin A, a circulating inhibitor of ectopic calcification, is downregulated in hemodialy...
Background: Iron supplementation is a common recommendation to chronic kidney disease patients under...
BACKGROUND/AIMS: Clinical studies have shown increased levels of hepcidin causing functional iron de...
<b><i>Background:</i></b> Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patient...
Calcifying atherosclerosis is an active process, which is controlled by calcification inhibitors and...